Pharmafile Logo
Pharmafocus logo
Advanced Search

cervical cancer

Showing 11 posts of 11 posts found.

sanofi_hq__boetie_hall_web

Sanofi’s Libtayo shows positive Phase III results in advanced cervical cancer

May 13, 2021
Libtayo, Sanofi, cemiplimab, cervical cancer

Regeneron Pharmaceuticals and Sanofi have announced today positive Phase III trial results investigating the PD-1 inhibitor Libtayo (cemiplimab) in patients …

News

Boys in UK to be given HPV vaccine

July 9, 2019
Manufacturing and Production HPV, HPV vaccine, Vaccine, cervical cancer, oncology, pharma

Boys in the United Kingdom will from September be given the human papilloma virus (HPV) vaccine, the government has said. …

News
512px-hpv_causing_cervical_cancer

Major review points to success of HPV vaccine, cervical cancer could be eradicated in developed nations

June 27, 2019
Research and Development Cancer, HPV, UK, cervical cancer, human papilloma virus, pharma, vaccines

A major new review published in The Lancet has supported the effectiveness of the human papilloma virus (HPV) vaccine in …

News

Battling cervical cancer in the developing world

June 6, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Doctors Without Borders, Medecins sans frontieres; cancer, cervical cancer, malawi, pharma

The non-profit humanitarian organization Medecins Sans Frontieres, or Doctors Without Borders, is well known for its work fighting on the …

Feature

HPV vaccine prevents 90% of cervical pre-cancer cases in Scotland, research shows

April 4, 2019
Research and Development HPV, Scotland, cervical cancer, immunity, vaccines, virus

Routine vaccination of girls in Scotland against HPV has led to a dramatic drop in cases of cervical cancer, according …

News
shutterstock_204190579

UK cervical cancer screening rates fall to 21-year low

November 28, 2018
Medical Communications, Research and Development Cancer, NHS, UK, cervical cancer, pharma

A report by NHS Digital has revealed that cervical cancer screening coverage has fallen to 71.4%, down from 72% in …

News
MedImmune building

MedImmune and Inovio collaborate on cancer vaccine

August 11, 2015
Manufacturing and Production, Research and Development AstraZeneca, HPV, Inovio, MedImmune, cancer vaccines, cervical cancer, oncology

MedImmune has entered into a license agreement and collaboration with Inovio, a biotechnology company developing DNA-based immunotherapies for cancer and …

News
roche_logo_shadow_7

FDA speedy review for new Avastin licence

July 16, 2014
Research and Development, Sales and Marketing Cancer, Roche, avastin, cervical cancer

The FDA has granted priority review status for Roche’s Avastin (bevacizumab) plus chemotherapy in women with persistent, recurrent or metastatic …

News
Gardasil

Gardasil better value for money than Cervarix, finds new study

September 28, 2011
Sales and Marketing Cervarix, Gardasil, HPV, cervical cancer

A new report by the Health Protection Agency has found that Gardasil is a more cost-effective vaccine for cervical cancer …

News

GSK-Merck back new developing world cancer charity

September 14, 2011
Medical Communications Cancer, GSK, Merck & Co, Pink Ribbon-Red Ribbon, breast cancer, cervical cancer

GlaxoSmithKline and Merck are among the backers of a new charity that focuses on preventing female cancers in developing countries. …

News
Roche building

Roche pulls out of vaccine alliance with Transgene

February 23, 2011
Research and Development HPV, HPV vaccine, Roche, TG4001, Transgene, cervical cancer, cervical lesions, human papilloma virus, vaccines

Roche has terminated its license agreement with Transgene for its HPV therapeutic vaccine TG4001. The vaccine is currently being tested …

News

Latest content

FDA approves Novartis’ Fabhalta for PNH treatment

December 6, 2023

Teva Pharmaceuticals shares phase 3 data for Ajovy as migraine treatment

December 6, 2023

British Medical Journal publishes letter calling on government to reduce rate of antidepressant prescribing

December 5, 2023

Genentech shares positive results from phase 3 trial for breast cancer treatment

December 5, 2023

Dr Stefano Gulià appointed as chief scientific officer of Kling Bio

December 5, 2023